Telix Pharmaceuticals Ltd (TLX) stock
TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
$8.86−0.06 (-0.73%)
Close on Nov 17, 2026Market cap $3.00BP/E –Yield –
Telix Pharmaceuticals pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Telix Pharmaceuticals's pe ratio was 74.3× on Feb 27, 2026.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Feb 27, 2026 | 74.3× | −2.5 |
| 2025 | Dec 31, 2025 | 76.7× | – |
See a number that looks wrong?